ArticleHaematologica2019

Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.

Clara Recasens-Zorzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.